- Only apply sPESI to patients with objectively confirmed acute pulmonary embolism.
- Toggle each of the six criteria ON if present, OFF if absent.
- The total (0 to 6) and the risk category update automatically.
- sPESI = 0 → low risk (predicted 30-day mortality 1.0%). Consider outpatient management or early discharge if right-ventricular (RV) function is normal, cardiac biomarkers (troponin, BNP) are normal, and the social situation supports it.
- sPESI ≥ 1 → high risk (predicted 30-day mortality 10.9%). Admit, obtain RV imaging and biomarkers, and tailor intensity of monitoring and reperfusion decisions to the resulting risk tier.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Apply sPESI as the first-line risk-stratification tool when the only immediate decision is low-risk vs. not low-risk — typically to screen for candidates for outpatient management of acute pulmonary embolism. The 2019 European Society of Cardiology (ESC) guidelines accept either sPESI or the original PESI for identifying the low-risk group.
Appropriate population
Adult patients with acute, objectively confirmed PE. Validated in cohorts spanning ambulatory outpatients to admitted inpatients. Most useful in the ED and on the first ward day, when disposition and anticoagulation strategy are being set.
When NOT to rely on sPESI alone
sPESI is a clinical score — it does not incorporate right-ventricular (RV) dysfunction on echocardiography or CT, or cardiac biomarkers (troponin, BNP). In the ESC pathway, a sPESI of 0 still requires normal RV function and normal cardiac biomarkers before a patient is truly low risk. Do not apply it to hemodynamically unstable patients (massive PE — they are high-risk by definition), pregnant patients, or patients with major unmeasured comorbidity.
Pearls & Pitfalls
Six yes/no items, no raw age
sPESI uses an age threshold (> 80 years), not raw years, which avoids the "age dominates the score" effect of the full PESI. The remaining five items collapse the 11 PESI variables into a workable bedside count: cancer, cardiopulmonary disease (combined), tachycardia, hypotension, and hypoxemia. In head-to-head validations the simplified score is non-inferior to the original PESI for the binary low- vs. high-risk decision.
What sPESI = 0 means in practice
In the Jiménez derivation cohort, sPESI = 0 was associated with a 30-day all-cause mortality of 1.0% (95% confidence interval or CI 0.0–2.1%) — i.e. a predicted mortality below the boundary at which outpatient management is considered safe. The HESTIA and HOT-PE trials used clinical criteria that overlap with sPESI = 0 and showed that outpatient treatment with a direct oral anticoagulant (DOAC) is safe in appropriately selected low-risk patients.
Pitfalls
(1) The "chronic cardiopulmonary disease" item is combined — heart failure, chronic lung disease, or either one together, is 1 point total (not 1 point each as in the original PESI). (2) The "arterial O₂ saturation < 90%" item counts whether on room air or on supplemental oxygen. (3) sPESI's hypotension item is < 100 mmHg — patients with systolic blood pressure < 90 mmHg (massive PE) are already high risk by hemodynamics and should not wait for a score. (4) "History of cancer" includes active or recently treated cancer, not remote history in remission.
Why Use It
The decision many PE patients need most quickly is simply "can this patient go home from the emergency department?" The original PESI answers this with five risk classes based on 11 variables. sPESI answers the same question with six yes/no items and a single binary cut-off, which is faster at the bedside and performs just as well for the low-risk decision. It is validated in multiple cohorts across ambulatory and inpatient settings, endorsed by the 2019 ESC guidelines, and is the score most commonly cited in outpatient-management trials (HESTIA, HOT-PE). Combined with imaging of right-ventricular function and cardiac biomarkers, sPESI underpins the pragmatic ESC pathway that identifies the subset of PE patients for whom hospitalization adds cost and iatrogenic harm without benefit.
Simplified PESI (sPESI)
Toggle each of the six criteria ON if present. The total (0 to 6) and the risk category update automatically.
⚕ Jiménez D et al. Arch Intern Med. 2010;170(15):1383–1389. sPESI stratifies 30-day all-cause mortality after confirmed acute pulmonary embolism into low (sPESI = 0; 1.0%) and high (sPESI ≥ 1; 10.9%). A sPESI of 0 identifies candidates for outpatient management per HESTIA / HOT-PE, provided right-ventricular function is normal, cardiac biomarkers are normal, and the social situation supports early discharge. For licensed clinicians; not a substitute for individualized clinical judgment.
Next Steps
Use the binary sPESI result as the first gate for outpatient management.
- sPESI = 0 (low risk, 30-day mortality 1.0%): Consider early discharge or fully outpatient management with a direct oral anticoagulant (DOAC) if right-ventricular (RV) function is normal on echocardiography or computed tomography pulmonary angiogram (CTPA), cardiac biomarkers (troponin, BNP) are normal, no severe comorbidity, and reliable social support (HESTIA / HOT-PE criteria).
- sPESI ≥ 1 (high risk, 30-day mortality 10.9%): Admit for inpatient anticoagulation and monitoring. Obtain echocardiography (RV dysfunction) and cardiac biomarkers; escalate to step-down or ICU if either is abnormal, and discuss reperfusion (systemic thrombolysis or catheter-directed therapy) with the PE response team for the intermediate-high ESC band.
- If a more granular five-class estimate of 30-day mortality is wanted — for example, to distinguish Class I vs. II for a young, otherwise well patient — use the full Pulmonary Embolism Severity Index (PESI).
Evidence & References
The Six sPESI Criteria
| Criterion | Points |
|---|---|
| Age > 80 years | +1 |
| History of cancer | +1 |
| History of chronic cardiopulmonary disease (heart failure OR chronic lung disease) | +1 |
| Pulse ≥ 110 bpm | +1 |
| Systolic blood pressure < 100 mmHg | +1 |
| Arterial O₂ saturation < 90% | +1 |
Interpretation
| sPESI | Risk | 30-day all-cause mortality | Implication |
|---|---|---|---|
| 0 | Low | 1.0% (95% CI 0.0 – 2.1%) | Candidate for outpatient management (with normal RV function and biomarkers) |
| ≥ 1 | High | 10.9% (95% CI 8.5 – 13.2%) | Admit; stratify further with RV imaging and cardiac biomarkers |
Jiménez and colleagues derived sPESI from a 15,531-patient RIETE cohort and validated it in an independent 7,106-patient cohort; it has subsequently been incorporated into the 2019 ESC guidelines and used as the entry criterion in multiple outpatient-management trials.
